The biotechnology company is ending development of a potential Alzheimer's disease drug after concluding it will be ineffective. Guess Inc., down ...
News
- Biogen and Guess slide while Darden and Micron rise
- Austin makes destination wish list of Columbus airport chief
Domestically, destinations also include San Diego, San Antonio and ... He said San Diego is a significant corporate hub, where a wealth of biotech and ... Austin sees 80 passengers a day, while San Antonio sees 76 and Kansas City ...
- Stocks move broadly higher, led by technology companies
Biogen, a major biotechnology company, took a 29 percent nosedive after stopping a trial for an Alzheimer's drug. Other health care stocks also fell.
- Will more genetically engineered foods be approved under the FDA's new leadership?
The plan includes public webinars on animal genome editing, as well as guidance on plant and animal biotechnology. Given the current scientific ...
- Edwards proposing $19M more for Louisiana higher education
Other dollars would pay for LSU's Pennington Biomedical Research Center to recruit faculty, an expense matched with private foundation money.